Table 2 Correlations between QIDS-SR16 scores and FIBSER scores at each study timepoint.

From: Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report

Timepoint

QIDS-SR16

FIBSER—Frequency

FIBSER—Intensity

FIBSER—Burden

M (SD)

M (SD)

N

r

p

M (SD)

N

r

p

M (SD)

N

r

p

Day 4

12.78 (4.27)

0.85 (1.46)

715

0.03

0.373

0.85 (1.32)

714

0.01

0.892

0.56 (1.11)

715

0.08

0.033

Week 2

10.4 (4.57)

1.37 (1.63)

699

0.16

<0.001

1.43 (1.46)

699

0.17

<0.001

0.88 (1.25)

699

0.23

<0.001

Week 4

9.20 (4.72)

1.34 (1.56)

673

0.24

<0.001

1.40 (1.38)

673

0.27

<0.001

0.90 (1.20)

673

0.33

<0.001

Week 6

8.48 (4.88)

1.16 (1.49)

619

0.35

<0.001

1.22 (1.33)

618

0.38

<0.001

0.81 (1.18)

619

0.39

<0.001

Week 8

7.63 (4.72)

1.19 (1.44)

688

0.27

<0.001

1.27 (1.32)

687

0.29

<0.001

0.85 (1.20)

688

0.34

<0.001

  1. FIBSER Frequency, Intensity, and Burden of Side Effects, QIDS-SR16 16-item Quick Inventory of Depression Symptomatology—Self Reported.